MPM BioImpact reported a 1.4% stake in Context Therapeutics CNTX · 1,299,046 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 1.4%
Last report: 11.6% · filed 26/02/17
Shares held: 1,299,046 sh
Class: Common Stock, par value $0.001 per share
Stock: Context Therapeutics CNTX
Holder: MPM BioImpact
Event date: 26/06/30
Filed: 26/08/14

1.4% stake · below 5%

Stake: 1.4%
Last report: 11.6%
Since last report: −10.2pp

Context Therapeutics trades, last 26 weeks

What else happened in Context Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

MPM BioImpact's other 5% stake reports

MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
6.2% stake
18,331,420 sh
6.2% stake
Filed 08/14
MPM BioImpact
5% stakeClimb Bio
5% stake
Climb Bio
CLYM
0% stake
0 sh
0% stake
Filed 08/14
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
8.8% stake
26,066,806 sh
8.8% stake
Filed 05/15
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
9.9% stake
24,579,307 sh
9.9% stake
Filed 02/17
MPM BioImpact
5% stakeClimb Bio
5% stake
Climb Bio
CLYM
5.6% stake
2,671,480 sh
5.6% stake
Filed 02/17